Symptoms of MS may be mild or severe, of long duration or short, and may appear in various combinations, depending on the area of the nervous system affected. Following a relapse, complete or partial ...

Briumvi (ublituximab-xiiy) is a prescription drug used to treat certain types of multiple sclerosis (MS). Briumvi can cause side effects that range from mild to serious. Examples include upper ...

Multiple sclerosis (MS) is characterized by a broad array of symptoms. Despite this variability, most individuals with MS will exhibit a distinct set of symptoms during their initial clinical attack.

Kesimpta is a medication used to treat relapsing forms of multiple sclerosis (MS) and clinically isolated syndrome (CIS). Kesimpta comes as a solution inside single-dose prefilled injection pens or ...

India is facing a significant challenge with autoimmune diseases, which affect about 5% to 8% of the population and can lead ...

Multiple sclerosis (MS) is a chronic autoimmune disease — one in which the body erroneously attacks itself — that affects the central nervous system. Specifically, MS develops when the immune system ...

Most people living with multiple sclerosis (MS), a condition that affects the central nervous system, experience periods of acute symptoms, called relapses or flares. During an MS flare, existing MS ...

Multiple sclerosis (MS) is a chronic autoimmune disorder of the central nervous system (CNS), including the brain, spinal cord, and optic nerves. The body mistakenly attacks and damages the protective ...

Learn how early diagnosis and modern therapies can prevent Multiple Sclerosis from leading to long-term disability.